May 4, 2023 12:51 PM EDTUpdated 03:16 PM

On heels of Essex deal, CRO Emmes says it's planning to make more acquisitions this year

Tyler Patchen

News Reporter

Emmes, a contract research organization that recently acquired Essex Management, said it has plans to make more “medium to larger scale deals” in Europe and …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER

On heels of Essex deal, CRO Emmes says it's planning to make more acquisitions this year

Tyler Patchen

News Reporter

Sign up to read this article for free.

COO / Head of Operations (Stealth Portfolio Company)‬ ‭

Autonomy Bio Inc.

San Francisco, CA 94107, USA

New fund will pressure flailing biotechs, as investor frustration boils over

FDA chief Makary talks expediting drug approvals, RIFs and the abortion pill

Akeso shares new data suggesting it can beat Keytruda on survival, wins China approval

AbbVie commits $10B to expand US footprint with the threat of tariffs ahead

J&J reports durability data for bladder cancer 'pretzel' drug after FDA filing

ADSTILADRIN® (nadofaragene firadenovec-vncg) – A Growing Body of Clinical Data and Real-World Evidence

On heels of Es­sex deal, CRO Emmes says it's plan­ning to make more ac­qui­si­tions this year

News Reporter

Sign up to read this article for free.

Autonomy Bio Inc.

San Francisco, CA 94107, USA

On heels of Essex deal, CRO Emmes says it's planning to make more acquisitions this year